Literature DB >> 22171261

The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence.

Marc Schweneker1, Susanne Lukassen, Michaela Späth, Michael Wolferstätter, Eveline Babel, Kay Brinkmann, Ursula Wielert, Paul Chaplin, Mark Suter, Jürgen Hausmann.   

Abstract

Sustained activation of the Raf/MEK/extracellular signal-regulated kinase (ERK) pathway in infected cells has been shown to be crucial for full replication efficiency of orthopoxviruses in cell culture. In infected cells, this pathway is mainly activated by the vaccinia virus growth factor (VGF), an epidermal growth factor (EGF)-like protein. We show here that chorioallantois vaccinia virus Ankara (CVA), but not modified vaccinia virus Ankara (MVA), induced sustained activation of extracellular signal-regulated kinase 1/2 (ERK1/2) in infected human 293 cells, although both viruses direct secretion of functional VGF. A CVA mutant lacking the O1L gene (CVA-ΔO1L) demonstrated that the O1 protein was required for sustained upregulation of the ERK1/2 pathway in 293 cells as well as in other mammalian cell lines. The highly conserved orthopoxvirus O1L gene encodes a predicted 78-kDa protein with a hitherto-unknown function. CVA-ΔO1L showed reduced plaque size and an attenuated cytopathic effect (CPE) in infected cell cultures and reduced virulence and spread from lungs to ovaries in intranasally infected BALB/c mice. Reinsertion of an intact O1L gene into MVA, which in its original form harbors a fragmented O1L open reading frame (ORF), restored ERK1/2 activation in 293 cells but did not increase replication and spread of MVA in human or other mammalian cell lines. Thus, the O1 protein was crucial for sustained ERK1/2 activation in CVA- and MVA-infected human cells, complementing the autocrine function of VGF, and enhanced virulence in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171261      PMCID: PMC3302380          DOI: 10.1128/JVI.06166-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.

Authors:  Ehud Katz; Brian M Ward; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus.

Authors:  J Rietdorf; A Ploubidou; I Reckmann; A Holmström; F Frischknecht; M Zettl; T Zimmermann; M Way
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

3.  Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  Honglin Luo; Bobby Yanagawa; Jingchun Zhang; Zongshu Luo; Mary Zhang; Mitra Esfandiarei; Christopher Carthy; Janet E Wilson; Decheng Yang; Bruce M McManus
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 4.  Regulation of tumor cell motility by ERK mitogen-activated protein kinases.

Authors:  Emmanuel Viala; Jacques Pouysségur
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

5.  Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation.

Authors:  K L Oie; D J Pickup
Journal:  Virology       Date:  2001-09-15       Impact factor: 3.616

6.  The block in assembly of modified vaccinia virus Ankara in HeLa cells reveals new insights into vaccinia virus morphogenesis.

Authors:  M Carmen Sancho; Sibylle Schleich; Gareth Griffiths; Jacomine Krijnse-Locker
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility.

Authors:  Emmanuel Vial; Erik Sahai; Christopher J Marshall
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

8.  Bombesin, lysophosphatidic acid, and epidermal growth factor rapidly stimulate focal adhesion kinase phosphorylation at Ser-910: requirement for ERK activation.

Authors:  Isabel Hunger-Glaser; Eduardo Perez Salazar; James Sinnett-Smith; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2003-04-11       Impact factor: 5.157

9.  Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion.

Authors:  Scott T Eblen; Jill K Slack-Davis; Adel Tarcsafalvi; J Thomas Parsons; Michael J Weber; Andrew D Catling
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 10.  Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery.

Authors:  Gerd Sutter; Caroline Staib
Journal:  Curr Drug Targets Infect Disord       Date:  2003-09
View more
  23 in total

1.  Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Authors:  Christine Pugh; Sarah Keasey; Lawrence Korman; Phillip R Pittman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-04-23

2.  Monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity.

Authors:  Livia V Patrono; Kamilla Pléh; Liran Samuni; Markus Ulrich; Caroline Röthemeier; Andreas Sachse; Silvia Muschter; Andreas Nitsche; Emmanuel Couacy-Hymann; Christophe Boesch; Roman M Wittig; Sébastien Calvignac-Spencer; Fabian H Leendertz
Journal:  Nat Microbiol       Date:  2020-04-27       Impact factor: 17.745

3.  Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.

Authors:  Marc Schweneker; Andrea S Laimbacher; Gert Zimmer; Susanne Wagner; Elisabeth M Schraner; Michael Wolferstätter; Marieken Klingenberg; Ulrike Dirmeier; Robin Steigerwald; Henning Lauterbach; Hubertus Hochrein; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

4.  Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.

Authors:  Michael Wolferstätter; Marc Schweneker; Michaela Späth; Susanne Lukassen; Marieken Klingenberg; Kay Brinkmann; Ursula Wielert; Henning Lauterbach; Hubertus Hochrein; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2014-10-08       Impact factor: 5.103

5.  Punctuated Evolution of Myxoma Virus: Rapid and Disjunct Evolution of a Recent Viral Lineage in Australia.

Authors:  Peter J Kerr; John-Sebastian Eden; Francesca Di Giallonardo; David Peacock; June Liu; Tanja Strive; Andrew F Read; Edward C Holmes
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

6.  A whole-genome RNA interference screen for human cell factors affecting myxoma virus replication.

Authors:  Wondimagegnehu M Teferi; Kristopher Dodd; Rob Maranchuk; Nicole Favis; David H Evans
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

7.  Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread.

Authors:  Peter J Kerr; Matthew B Rogers; Adam Fitch; Jay V Depasse; Isabella M Cattadori; Alan C Twaddle; Peter J Hudson; David C Tscharke; Andrew F Read; Edward C Holmes; Elodie Ghedin
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

8.  Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice.

Authors:  Hajime Kurosaki; Motomu Nakatake; Teruhisa Sakamoto; Nozomi Kuwano; Masato Yamane; Kenta Ishii; Yoshiyuki Fujiwara; Takafumi Nakamura
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

Review 9.  Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.

Authors:  Peter J Kerr; June Liu; Isabella Cattadori; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  Viruses       Date:  2015-03-06       Impact factor: 5.048

10.  A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses.

Authors:  Sonia T Wennier; Kay Brinkmann; Charlotte Steinhäußer; Nicole Mayländer; Claudia Mnich; Ursula Wielert; Ulrike Dirmeier; Jürgen Hausmann; Paul Chaplin; Robin Steigerwald
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.